9-34648421-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000155.4(GALT):​c.652C>T​(p.Leu218Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0337 in 1,614,124 control chromosomes in the GnomAD database, including 1,339 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign,other (★★).

Frequency

Genomes: 𝑓 0.028 ( 99 hom., cov: 32)
Exomes 𝑓: 0.034 ( 1240 hom. )

Consequence

GALT
NM_000155.4 synonymous

Scores

2

Clinical Significance

Benign; other criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: 0.837

Publications

36 publications found
Variant links:
Genes affected
GALT (HGNC:4135): (galactose-1-phosphate uridylyltransferase) Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
GALT Gene-Disease associations (from GenCC):
  • classic galactosemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • galactosemia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 9-34648421-C-T is Benign according to our data. Variant chr9-34648421-C-T is described in ClinVar as Benign|other. ClinVar VariationId is 39372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.837 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0957 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALTNM_000155.4 linkc.652C>T p.Leu218Leu synonymous_variant Exon 7 of 11 ENST00000378842.8 NP_000146.2
GALTNM_001258332.2 linkc.325C>T p.Leu109Leu synonymous_variant Exon 5 of 9 NP_001245261.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALTENST00000378842.8 linkc.652C>T p.Leu218Leu synonymous_variant Exon 7 of 11 1 NM_000155.4 ENSP00000368119.4
ENSG00000258728ENST00000556278.1 linkc.397C>T p.Leu133Leu synonymous_variant Exon 4 of 8 5 ENSP00000451792.1

Frequencies

GnomAD3 genomes
AF:
0.0279
AC:
4250
AN:
152144
Hom.:
100
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0119
Gnomad AMI
AF:
0.0637
Gnomad AMR
AF:
0.0223
Gnomad ASJ
AF:
0.0597
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.0425
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0310
Gnomad OTH
AF:
0.0354
GnomAD2 exomes
AF:
0.0373
AC:
9391
AN:
251466
AF XY:
0.0415
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.0167
Gnomad ASJ exome
AF:
0.0608
Gnomad EAS exome
AF:
0.000489
Gnomad FIN exome
AF:
0.0401
Gnomad NFE exome
AF:
0.0320
Gnomad OTH exome
AF:
0.0384
GnomAD4 exome
AF:
0.0343
AC:
50139
AN:
1461862
Hom.:
1240
Cov.:
33
AF XY:
0.0367
AC XY:
26696
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.0127
AC:
426
AN:
33480
American (AMR)
AF:
0.0175
AC:
783
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0623
AC:
1627
AN:
26136
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39700
South Asian (SAS)
AF:
0.104
AC:
9012
AN:
86258
European-Finnish (FIN)
AF:
0.0398
AC:
2124
AN:
53412
Middle Eastern (MID)
AF:
0.0664
AC:
383
AN:
5766
European-Non Finnish (NFE)
AF:
0.0301
AC:
33451
AN:
1111992
Other (OTH)
AF:
0.0384
AC:
2322
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3361
6723
10084
13446
16807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1296
2592
3888
5184
6480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0279
AC:
4248
AN:
152262
Hom.:
99
Cov.:
32
AF XY:
0.0292
AC XY:
2177
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0118
AC:
491
AN:
41552
American (AMR)
AF:
0.0222
AC:
339
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0597
AC:
207
AN:
3466
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5172
South Asian (SAS)
AF:
0.103
AC:
498
AN:
4824
European-Finnish (FIN)
AF:
0.0425
AC:
451
AN:
10618
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0310
AC:
2109
AN:
68016
Other (OTH)
AF:
0.0350
AC:
74
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
211
422
633
844
1055
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0292
Hom.:
208
Bravo
AF:
0.0233
Asia WGS
AF:
0.0420
AC:
145
AN:
3478
EpiCase
AF:
0.0382
EpiControl
AF:
0.0356

ClinVar

Significance: Benign; other
Submissions summary: Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase Benign:7
Sep 23, 2014
GeneReviews
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 19, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3Other:1
Feb 05, 2015
Eurofins Ntd Llc (ga)
Significance:other
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles).

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 11, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Galactosemia Benign:1
Mar 29, 2017
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
6.0
DANN
Benign
0.82
PhyloP100
0.84
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070075; hg19: chr9-34648418; API